On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trials

During this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:

  • Cognitive domains – which ones should we focus on?
  • Are current ‘gold standard’ cognitive outcome measures fit for purpose?
  • Is the MMSE the best metric for selecting Alzheimer’s trial study participants?
  • Statistically significant, but is it clinically relevant?

You can watch the replay below: